+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effect of autologous fibrin sealant (Vivostat) on morbidity after pulmonary lobectomy: a prospective randomised, blinded study



The effect of autologous fibrin sealant (Vivostat) on morbidity after pulmonary lobectomy: a prospective randomised, blinded study



European Journal of Cardio-Thoracic Surgery 26(6): 1187-1191



Postoperative air leakage is the most frequent complication after pulmonary surgery. The development of modern surgical techniques has been influenced strongly by the need to manage air leakage effectively during pulmonary resection. This study evaluated the effect of using an autologous fibrin sealant (Vivostat) during lobectomy on morbidity following surgery. This was a prospective, blinded, randomised clinical study. Patients undergoing lobectomy were enrolled into two groups (Vivostat or non-treatment control, 20 per group). Air leakage was measured over a 1-h period (using a mechanical suction pump) on the day of operation, and both air leakage and bleeding/exudation (drainage volume) were recorded every morning postoperatively until the chest tubes were removed. Personnel recording these parameters were blinded to the intervention received. Compared with the control group, mean bleeding/exudate volumes were significantly reduced in the Vivostat group (day 1,370 vs. 525 ml; total, 424 vs. 782 ml; both P<0.001), and drains were inserted for a shorter time (medians, 1 vs. 2 days, P=0.07). Significantly fewer patients had air leakage at any time in the Vivostat group (40 vs. 80%, P=0.02), and air leakage volumes were significantly lower compared with the control group (median differences: day of surgery: 0.6l/min, P=0.01; total 0.8l/min, P=0.03). Postoperative hospitalisation time was shorter in the Vivostat group than in the control group but the difference was not significant (0.5 days, P=0.12). Vivostat fibrin sealant significantly reduces post-surgical air leakage and drainage volumes following lobectomy in pulmonary surgery and is suitable for routine use in this procedure.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050610000

Download citation: RISBibTeXText

PMID: 15541982

DOI: 10.1016/j.ejcts.2004.08.009


Related references

Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel. Biomaterials 26(31): 6233-6241, 2005

Vivostat®: an autologous fibrin sealant as useful adjunct in endoscopic transnasal CSF-leak repair. European Archives of Oto-Rhino-Laryngology 272(6): 1423-1427, 2015

Autologous fibrin sealant (Vivostat(®)) in the neurosurgical practice: Part I: Intracranial surgical procedure. Surgical Neurology International 6: 77, 2015

Autologous fibrin sealant (Vivostat) for mesh fixation in laparoscopic transabdominal preperitoneal hernia repair. Endoscopy 38(8): 841-844, 2006

Vivostat system autologous fibrin sealant: Preliminary study in elective coronary bypass grafting. Annals of Thoracic Surgery 66(2): 482-486, 1998

Autologous fibrin sealant reduces the incidence of prolonged air leak and duration of chest tube drainage after lung volume reduction surgery: a prospective randomized blinded study. Journal of Thoracic and Cardiovascular Surgery 136(4): 843-849, 2008

A comparison of the haemostatic effect of Vivostat patient-derived fibrin sealant with oxidised cellulose in multiple surgical procedures. European Surgical Research 35(5): 439-444, September-October, 2003

Hemostatic effect of Vivostat patient-derived fibrin sealant on split-thickness skin graft donor sites. Annals of Plastic Surgery 50(4): 367-372, 2003

A Comparison of the Haemostatic Effect of Vivostat ® Patient-Derived Fibrin Sealant with Oxidised Cellulose (Surgicel ® ) in Multiple Surgical Procedures. European Surgical Research 35(5): 439-444, 2003

A comparison of the haemostatic effect of Vivostat patient-derived fibrin sealant with oxidised cellulose (Surgicel) in multiple surgical procedures. European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes 35(5): 439-444, 2003

Vivostat system for the preparation of a new class of fibrin sealant. Blood Coagulation & Fibrinolysis 9(7): 718, 1998

Bleeding from the sternal marrow can be stopped using vivostat patient-derived fibrin sealant. Annals of Thoracic Surgery 69(4): 1173-1175, 2000

Reproducibility of the mechanical properties of Vivostat system patient-derived fibrin sealant. Biomaterials 23(10): 2249-2254, 2002

Prevention of air leakage by spraying vivostat fibrin sealant after lung resection in pigs. Chest 117(4): 1124-1127, 2000

Lung sealant and morbidity after pleural decortication: a prospective randomized, blinded study. Journal of Cardiothoracic Surgery 5: 45, 2010